Vera Therapeutics (VERA) Non Operating Income (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Non Operating Income data on file, last reported at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 25.45% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $14.5 million (down 18.74% YoY), and the FY2025 full-year result was $15.9 million, up 5.56% from the prior year.
• Non Operating Income for Q1 2026 stood at $4.1 million, up from $3.1 million in the prior quarter.
• Across five years, Non Operating Income topped out at $5.5 million in Q1 2025 and bottomed at -$64000.0 in Q1 2022.
• The 5-year median for Non Operating Income is $2.7 million (2024), against an average of $2.5 million.
• The widest annual swing landed in 2022, when Non Operating Income tumbled 3300.0%; it then jumped 1957.81% in 2023.
• A 5-year view of Non Operating Income shows it stood at $1.1 million in 2022, then increased by 20.21% to $1.4 million in 2023, then surged by 299.56% to $5.5 million in 2024, then plunged by 43.35% to $3.1 million in 2025, then surged by 31.83% to $4.1 million in 2026.
• The last three Non Operating Income figures came in at $4.1 million (Q1 2026), $3.1 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.

Peer Comparison